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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A136Methods: Cartilage slices were obtained from the advanced OA patients
(age 45-80 years) undergoing knee replacement surgery. Non-arthritic
knee cartilages were obtained from autopsy patients within 24h (NDRI,
Philadelphia). Three different rodent OA models, such as anterior cru-
ciate ligament transection (ACLT) and medial meniscectomy (MM) and
combination of both ACLT and MM models were performed. Prede-
signed TaqMan PCR primers were purchased from Applied Biosystems.
siRNA targeting periostin were purchased from Sigma. Matrix metal-
loproteinases proMMP-1 and proMMP-13 ELISA kits were from R&D
Systems. Degradation products of type II collagen was measured using
C1,2C - ELISA assay kit.
Results: Elevated expression of periostin (2-4 fold; p¼0.004) was
observed in OA compared to non-diseased control cartilage. Veriﬁcation
by real-time PCR, immunohistochemistry and immunoblot conﬁrmed
periostin upregulation in OA cartilage. In three different model of sur-
gical-induction of OA in rodents, such as anterior cruciate ligament
transection (ACLT) and destabilization of the medial meniscus (DMM)
and combination of both ACLT and MM models, periostin expression
signiﬁcantly increased (3-11 fold; p¼0.001) from 4-8 weeks after sur-
gery. In functional assays, exogenously added (1-10 mg/ml) or adeno-
virus mediated overexpression of periostin signiﬁcantly increased
MMP-13 (p<0.001) and ADAMTS4 (p<0.03) expression and activity
(p<0.02) in primary human OA and mouse chondrocytes. Conversely;
knock down of endogenous periostin using siRNA signiﬁcantly
decreased constitutive MMP-13 expression. In OA cartilage explants
cultures, periostin increased cartilage degradation, evidenced by
increased release of collagen (C1, 2C) and GAG fragments in culture
supernatants. Periostin selectively activates Wnt signaling and induc-
tion of MMP-13 and ADAMTS4 expression is mediated by b-catenin
signaling and inhibited by the Wnt inhibitor CCT031374 hydrobromide.
Conclusions: These ﬁndings characterize periostin as a catabolic
extracellular matrix protein in OA cartilage, where it acts via the can-
onical Wnt signaling pathway to promote cartilage degradation by
upregulating MMP-13 and aggrecanase expression. Therefore, periostin
may represent a novel therapeutic target to prevent OA progression.
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CARTILAGE SPECIFIC DELETION OF MITOGEN INDUCIBLE GENE 6 IN
MICE INCREASES ARTICULAR CARTILAGE THICKNESS IN LATE
ADULTHOOD
M.A. Pest y, B. Russell y, J.-W. Jeong z, F. Beier y. yUniv. of Western Ontario,
London, ON, Canada; zMichigan State Univ., Grand Rapids, MI, USA
Purpose: Osteoarthritis (OA) is a degenerative joint disease which is
characterized by the progressive loss of articular cartilage thickness and
overall joint degeneration. There are currently no treatments to slow,
stop or reverse joint destruction, and so therapeutics for OA only mit-
igate symptoms of pain/stiffness. Mitogen inducible gene 6 (Mig-6)
negatively regulates epidermal growth factor (EGFR) signalling which is
important in cartilage homeostasis (Appleton et al, 2010). We have
shown previously that loss of Mig-6 in mouse cartilage results in
increased articular cartilage thickness and ectopic formation of chon-
dro-osseous nodules in the knee (Pest et al, 2014). However, it is unclear
whether these anabolic effects are observed in other joints, and if
altered cartilage homeostasis can be induced post-natally.
Purpose: To determine 1) the role of Mig-6 in maintaining cartilage
anabolism when deleted in post-natal mouse cartilage, 2) the anabolic
effects of Mig-6 loss in multiple joints and at multiple ages, and 3)
whether this phenotype can be rescued by deletion of EGFR ligand
TGFalpha.
Methods: Selective knockout of Mig-6 in cartilage was achieved
through the use of the Cre-lox system, by breeding “ﬂoxed”Mig-6 (Mig-
6ﬂ/ﬂ) mice to either animals with Cre driven by Col2a1 promoter (Col2-
Creþ/-) or to animals with an inducible Col2a1 driven Cre (Col2a1-
CreERT2þ/-). Col2-Cre mice were aged to 15 and 21 months of age to
examine cartilage anabolism and formation of ectopic chondro-osseous
nodules late in life. 21 month old mice were scanned by MicroCT at 50
mm/voxel resolutions to examine changes in bone morphology and
ectopic nodule formation. Cre-mediated recombination in Col2-CreER
mice was induced by 5 day tamoxifen injection in 3week old mice. Mice
with deletion of TGFalpha were bred to Mig-6 KO mice to evaluate the
role of this EGFR ligand in the anabolic phenotype. Histological sections
of knee, ankle, elbow and spine articular joints were collected and joint
morphology was examined using various stains including Safranin O/fast green, toluidine blue and picrosirius red. Immunohistochemistry
(IHC) was used to evaluate molecular changes in joint tissues.
Results: Anabolic increase in the cartilage thickness of the elbow and
ankle was observed up to the age of 21 months in Mig-6 knockout mice
(KO, Mig-6ﬂ/ﬂ;Col2-Creþ/-) when compared to Control mice (Mig-6ﬂ/
ﬂ;Col2-Cre-/- or Mig-6ﬂ/þ;Col2-Cre-/-). Ectopic chondro-osseous nod-
ules were identiﬁed only in the knee joints and spines of KO mice by
MicroCT evaluation and histology. Phospho-ERK staining in these tis-
sues was increased in KO mice compared to control, indicating
increased EGFR signalling. Deletion of TGFalpha in Mig6 KO did not
prevent formation of chondro-osseous nodules in the knee as late as 12
weeks of age.
Conclusions: The anabolic effects of Mig6 loss in mouse cartilage can
persist late into adulthood, however the exact mechanism is still
unclear. Mig6 and the EGFR signalling pathway may be promising tar-
gets for the development of therapeutic interventions which induce
cartilage anabolism and repair in OA diseased tissue.
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XENOESTROGENS DISRUPT TYPE 2 COLLAGEN EXPRESSION IN
CHONDROCYTES IN VITRO.
M.T. Corvol, Sr., T. Auxietre, M.-F. Dumontier, O. Kellerman,
J.-F. Savouret. INSERM, Paris, France
Purpose: In recent years chemicals with endocrine properties, called
Endocrine Disrupting Compounds (EDC), have become a topic of sci-
entiﬁc and public discussion. In the ﬁeld of osteoarthritic pathologies,
EDC compounds that mimic estrogenic agonists or antagonists are of
major concern, because of the central role of estrogens in skeletal
developmental processes (ref). EDC are acting on their target genes
upon binding the aryl hydrocarbon receptor (AhR). During the ten past
years, interactions between estrogen receptor (ER) and some xeno-
biotic-activated AhR have been well demonstrated. Very few studies
have been reported on EDC effects on bone or cartilage. Our laboratory
recently studied the effects of low doses and cocktail xenoestrogens on
rat cartilage development in vivo, by using a rodent gestational/lacta-
tional model (T.A. Auxietre, et al, 2014). We observed transient mod-
iﬁcations of caudal vertebral body associated with a decrease in growth
plate cartilage thickness with greater impact on the hypertrophic
chondrocyte zone. We inferred from these data that the tested com-
pounds could interfere with the dynamic of chondrogenic differ-
entiation and/or maturation processes, possibly by impacting type 2
collagen (Col2), one of the the major components of cartilage that
assures cartilage function.
The present work was aimed to study the in vitro effects of two xen-
oestrogens (genistein, G; bisphenol A, BPA) and one anti-androgen
(vinclozolin, V) and its metabolite M2 on Col2 expression in two dif-
ferent models of cultured chondrocytes: during the process of chon-
drogenic induction and in mature chondrocytes.
Methods: A murine stem cell line inducible towards chondrogenesis
(C1) was used for dynamic studies of differentiation using chondrogenic
and non-chondrogenic markers. In parallel, post-natal murine chon-
drocytes were used for steady-state investigations in differentiated
chondrocytes in primary culture (P0) or after dedifferentiation by pas-
sages (P3) or FGF2 treatment. Biological markers were studied at the
mRNA (qPCR) and protein (western blot) levels. COL2A protein
expression was evaluated by western blot and immunocytochemistry
by using an antibody which only recognizes the speciﬁc COL2A N-ter-
minal propeptide. Fulvestrant and SB 203580 were used respectively as
speciﬁc inhibitors of ER or p38MEK pathways. Implication of Tia1-
splicing was shown after cell transfectionwith speciﬁc anti-Tia1 siRNAs.
Results: Vinclozolin was practically inactive. M2, alone or combined
with G or BPA, modiﬁed the dynamic of Col2A immature isoform of
COL2 during chondrogenic induction. These compounds extended the
basal expression of COL2A and delayed its replacement by the mature
isoform COL2B in C1 cells. This effect was dose dependent with max-
imum at 10-6M. In post natal chondrocytes, COL2A expression
increased with cell dedifferentiation or FGF2 treatment. EDC were
inactive on differentiated chondrocytes while COL2A doubled upon M2,
G and BPA addition in dedifferentiated cells. Estrogen receptor (ER) and
the p38-MEK pathway were involved. As these effects were only partly
transcriptional, we investigated and found an effect of FGF2 on Tia-1
splice protein expression. EDC showed no effects on other chondrogenic
markers (SOX9, Aggrecan, Col10a1) nor non-chondrogenic markers.
